Arbutus Biopharma Corp. (ABUS)
5.075
0.00 (0.00%)
USD |
NASDAQ |
Sep 01, 12:01
Arbutus Biopharma Cash and Short Term Investments (Quarterly) : 92.62M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.62M |
| March 31, 2026 | 95.23M |
| December 31, 2025 | 91.47M |
| September 30, 2025 | 93.70M |
| June 30, 2025 | 98.09M |
| March 31, 2025 | 112.71M |
| December 31, 2024 | 122.62M |
| September 30, 2024 | 127.79M |
| June 30, 2024 | 141.99M |
| March 31, 2024 | 129.24M |
| December 31, 2023 | 126.00M |
| September 30, 2023 | 134.18M |
| June 30, 2023 | 152.48M |
| March 31, 2023 | 146.73M |
| December 31, 2022 | 146.91M |
| September 30, 2022 | 134.72M |
| June 30, 2022 | 150.20M |
| March 31, 2022 | 165.48M |
| December 31, 2021 | 155.32M |
| September 30, 2021 | 121.40M |
| June 30, 2021 | 78.38M |
| March 31, 2021 | 131.96M |
| December 31, 2020 | 123.27M |
| September 30, 2020 | 118.30M |
| June 30, 2020 | 82.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 84.89M |
| December 31, 2019 | 90.83M |
| September 30, 2019 | 90.08M |
| June 30, 2019 | 95.28M |
| March 31, 2019 | 110.59M |
| December 31, 2018 | 124.62M |
| September 30, 2018 | 142.02M |
| June 30, 2018 | 154.87M |
| March 31, 2018 | 172.54M |
| December 31, 2017 | 126.35M |
| September 30, 2017 | 88.18M |
| June 30, 2017 | 103.01M |
| March 31, 2017 | 110.38M |
| December 31, 2016 | 130.56M |
| September 30, 2016 | 149.68M |
| June 30, 2016 | 165.31M |
| March 31, 2016 | 172.57M |
| December 31, 2015 | 181.30M |
| September 30, 2015 | 196.10M |
| June 30, 2015 | 207.20M |
| March 31, 2015 | 232.28M |
| December 31, 2014 | 112.16M |
| September 30, 2014 | 108.76M |
| June 30, 2014 | 117.23M |
| March 31, 2014 | 134.36M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Moderna, Inc. | 5.138B |
| Insmed, Inc. | 1.160B |
| Pfizer Inc. | 11.70B |
| Gossamer Bio, Inc. | 57.03M |
| Legend Biotech Corp. | 964.63M |